Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript
02:22pm, Wednesday, 03'rd Jun 2026
Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?
10:16am, Monday, 01'st Jun 2026
Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
08:00am, Friday, 29'th May 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
07:00am, Friday, 29'th May 2026
Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects
07:00am, Thursday, 28'th May 2026
New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatment BURLINGTON, N.C., May 28, 2026 /PRNewswir
LH or MEDP: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 27'th May 2026
Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Medpace (MEDP). But which of these two stocks offers value investors a better bang fo
Labcorp to Present at the Jefferies Global Healthcare Conference
08:00am, Wednesday, 27'th May 2026
BURLINGTON, N.C., May 27, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will present at the 2026 Jeffer
Labcorp (LH) Upgraded to Buy: Here's What You Should Know
01:01pm, Friday, 22'nd May 2026
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Should You Continue to Hold Labcorp Stock in Your Portfolio?
11:31am, Friday, 22'nd May 2026
LH gains from specialty testing growth, acquisitions and AI initiatives, but currency swings and macro pressures remain risks.
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
10:40am, Wednesday, 20'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time
07:00am, Wednesday, 20'th May 2026
MyLabcorp connects lab results, educational content and AI-enabled features in a secure, personalized mobile experience Leverages OpenAI models designed to help users understand their results, ask que
Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems
07:00am, Tuesday, 12'th May 2026
Labcorp's full test menu will be available through Epic's Aura platform Integration builds on the successful deployment of Invitae genetic testing and accelerates access to the latest genetic and spec
LH vs. CRL: Which Stock Is the Better Value Option?
12:41pm, Friday, 08'th May 2026
Investors interested in stocks from the Medical Services sector have probably already heard of Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two stocks offers value in
Here's Why Labcorp (LH) Is a Great 'Buy the Bottom' Stock Now
10:56am, Wednesday, 06'th May 2026
Labcorp (LH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend
LH Stock Up in Pre-Market on Q1 Earnings & Revenue Beat, 2026 View Up
01:55pm, Thursday, 30'th Apr 2026
Labcorp's shares rise after Q1 beats on earnings and revenues, with growth across segments and a higher 2026 outlook signaling continued momentum.
